Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1999;33:266-270

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tamaki, S.
Right arrow Articles by Kinoshita, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tamaki, S.
Right arrow Articles by Kinoshita, M.

(Hypertension. 1999;33:266-270.)
© 1999 American Heart Association, Inc.


Scientific Contributions

Genetic Polymorphism of CYP11B2 Gene and Hypertension in Japanese

Shinji Tamaki; Naoharu Iwai; Yasuyuki Tsujita; Masahiko Kinoshita

From the First Department of Internal Medicine, Shiga University of Medical Science, Tsukinowa, Seta, Otsu-city, Shiga-ken, Japan.

Correspondence to Naoharu Iwai, MD, First Department of Internal Medicine, Shiga University of Medical Science, Tsukinowa Seta, Otsu-city 520-2192, Shiga-ken, Japan. E-mail iwai{at}suncuore.shiga-med.ac.jp

Abstract—Low-renin hypertension is characterized by a high ratio of aldosterone to plasma renin activity (ALD/PRA), which may suggest inappropriately increased aldosterone biosynthesis. The genes for the enzymes involved in aldosterone synthesis may contribute to low-renin hypertension. We investigated the associations between genetic variations of CYP11B2 (aldosterone synthase) T(-344)C and hypertension in 482 Japanese subjects. Subjects older than 50 years with a blood pressure <140/85 mm Hg were considered normotensive (n=227 subjects), and subjects younger than 65 years old with a BP >160/95 mm Hg were considered hypertensive (n=255 subjects). The frequency of the TC+CC genotypes in the normotensive group was significantly lower than in the hypertensive group. Logistic analysis on 482 subjects revealed that body mass index, gender, and the genotype of CYP11B2 T(-344)C were significantly associated with hypertension. ALD and PRA were assessed in 97 subjects with hypertension, and the TC+CC genotypes were significantly associated with higher ALD/PRA. Sixty-five subjects with hypertension were assessed by 24-hour ambulatory blood pressure monitoring, and the frequency of nondippers (a difference in mean blood pressure of <10% between the daytime [6 AM to 9 PM] and nighttime [9 PM to 6 AM] hours) was significantly higher in subjects with the TC+CC (hetero+homo mutation) genotype than in subjects with the TT (wild-type) genotype. Echocardiographic assessment (n=136) revealed that the ratio of left ventricular end-diastolic dimension to height tended to be higher in subjects with the TC+CC genotype than in subjects with the TT genotype. The present study suggests that the (-344)C allele of the CYP11B2 gene may be a genetic marker for low-renin hypertension in Japanese.


Key Words: genetics • CYP11B2 • aldosterone • renin • blood pressure monitoring, ambulatory • hypertension, low-renin




This article has been cited by other articles:


Home page
In VivoHome page
A. GLUBA, M. BANACH, D. P. MIKHAILIDIS, and J. RYSZ
Genetic Determinants of Cardiovascular Disease: The Renin-Angiotensin-Aldosterone System, Paraoxonases, Endothelin-1, Nitric Oxide Synthase and Adrenergic Receptors
In Vivo, September 1, 2009; 23(5): 797 - 812.
[Abstract] [Full Text] [PDF]


Home page
Ther Adv Cardiovasc DisHome page
G. Escher
Hyperaldosteronism in pregnancy
Therapeutic Advances in Cardiovascular Disease, April 1, 2009; 3(2): 123 - 132.
[Abstract] [PDF]


Home page
HypertensionHome page
N. Iwai, K. Kajimoto, H. Tomoike, and N. Takashima
Polymorphism of CYP11B2 Determines Salt Sensitivity in Japanese
Hypertension, April 1, 2007; 49(4): 825 - 831.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
H. Imrie, M. Freel, B. M. Mayosi, E. Davies, R. Fraser, M. Ingram, H. J. Cordell, M. Farrall, P. J. Avery, H. Watkins, et al.
Association between Aldosterone Production and Variation in the 11{beta}-Hydroxylase (CYP11B1) Gene
J. Clin. Endocrinol. Metab., December 1, 2006; 91(12): 5051 - 5056.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
N. Makhanova, M. L.S. Sequeira-Lopez, R. A. Gomez, H.-S. Kim, and O. Smithies
Disturbed Homeostasis in Sodium-Restricted Mice Heterozygous and Homozygous for Aldosterone Synthase Gene Disruption
Hypertension, December 1, 2006; 48(6): 1151 - 1159.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
H. Tanahashi, T. Mune, Y. Takahashi, M. Isaji, T. Suwa, H. Morita, N. Yamakita, K. Yasuda, T. Deguchi, P. C. White, et al.
Association of Lys173Arg Polymorphism with CYP11B2 Expression in Normal Adrenal Glands and Aldosterone-Producing Adenomas
J. Clin. Endocrinol. Metab., November 1, 2005; 90(11): 6226 - 6231.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
P. Meneton, X. Jeunemaitre, H. E. de Wardener, and G. A. Macgregor
Links Between Dietary Salt Intake, Renal Salt Handling, Blood Pressure, and Cardiovascular Diseases
Physiol Rev, April 1, 2005; 85(2): 679 - 715.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
P. C. White and W. E. Rainey
Polymorphisms in CYP11B Genes and 11-Hydroxylase Activity
J. Clin. Endocrinol. Metab., February 1, 2005; 90(2): 1252 - 1255.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
P. Stella, G. Bigatti, L. Tizzoni, C. Barlassina, C. Lanzani, G. Bianchi, and D. Cusi
Association between aldosterone synthase (CYP11B2) polymorphism and left ventricular mass in human essential hypertension
J. Am. Coll. Cardiol., January 21, 2004; 43(2): 265 - 270.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
J. Nicod, D. Bruhin, L. Auer, B. Vogt, F. J. Frey, and P. Ferrari
A Biallelic Gene Polymorphism of CYP11B2 Predicts Increased Aldosterone to Renin Ratio in Selected Hypertensive Patients
J. Clin. Endocrinol. Metab., June 1, 2003; 88(6): 2495 - 2500.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
P. O. Lim, T. M. Macdonald, C. Holloway, E. Friel, N. H. Anderson, E. Dow, R. T. Jung, E. Davies, R. Fraser, and J. M. C. Connell
Variation at the Aldosterone Synthase (CYP11B2) Locus Contributes to Hypertension in Subjects with a Raised Aldosterone-to-Renin Ratio
J. Clin. Endocrinol. Metab., September 1, 2002; 87(9): 4398 - 4402.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
C. Hengstenberg, S. R. Holmer, B. Mayer, H. Lowel, S. Engel, H.-W. Hense, G. A. J. Riegger, and H. Schunkert
Evaluation of the Aldosterone Synthase (CYP11B2) Gene Polymorphism in Patients With Myocardial Infarction
Hypertension, March 1, 2000; 35(3): 704 - 709.
[Abstract] [Full Text] [PDF]